Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

UCSF launches new initiative to accelerate prostate cancer research

UCSF launches new initiative to accelerate prostate cancer research

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

Scientists identify new family of drugs which could combat prostate cancer

Scientists identify new family of drugs which could combat prostate cancer

Mitochondrial fission factor could represent a promising target for cancer therapy

Mitochondrial fission factor could represent a promising target for cancer therapy

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Men with prostate cancer can have healthy sex lives after surgery

Men with prostate cancer can have healthy sex lives after surgery

Pre-SRT PSA could serve as prognostic and predictive biomarker of benefit from hormone therapy

Pre-SRT PSA could serve as prognostic and predictive biomarker of benefit from hormone therapy

PSA testing can help detect prostate cancer in men with BRCA2 gene fault

PSA testing can help detect prostate cancer in men with BRCA2 gene fault

Clinicians and leading experts come together to address regional stroke divide

Clinicians and leading experts come together to address regional stroke divide

Researchers are working to develop new biosensor for detecting recurrence of prostate cancer

Researchers are working to develop new biosensor for detecting recurrence of prostate cancer

Non-invasive accurate blood test for prostate cancer

Non-invasive accurate blood test for prostate cancer

Genetic testing may help patients with metastatic breast cancer

Genetic testing may help patients with metastatic breast cancer

Simple blood test found to efficiently, accurately detect aggressive prostate cancer

Simple blood test found to efficiently, accurately detect aggressive prostate cancer

Excess weight linked with poorer psychosocial health among cancer patients

Excess weight linked with poorer psychosocial health among cancer patients

Regular mushroom intake may help prevent prostate cancer

Regular mushroom intake may help prevent prostate cancer

Gold nanoparticles used successfully in prostate tumour trial

Gold nanoparticles used successfully in prostate tumour trial

New therapy may kill cancer cells in inherited breast cancer

New therapy may kill cancer cells in inherited breast cancer

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors